Broadcom
AVGO
$345.22
+3.99%
Broadcom Inc. is one of the world's largest semiconductor and infrastructure software companies, designing custom AI accelerators, networking and connectivity chips, and selling virtualization, infrastructure, and security software to hyperscalers, enterprises, and governments. The company is a platform consolidator built through serial acquisitions (legacy Broadcom/Avago, VMware, Brocade, CA, Symantec) and has become the preeminent merchant supplier of custom ASICs for hyperscale AI workloads, positioning it as a direct beneficiary of the AI infrastructure supercycle alongside Nvidia and TSMC. The current investor debate centers on the durability and concentration of AI custom-silicon revenue — which management recently disclosed surged 221% to $16.7 billion — versus the stock's sharp ~29% drawdown from record highs, driven by concerns over single-customer exposure (notably Anthropic and Google), financing structures for AI chip purchases, and a broader rotation out of richly valued AI semis. Bulls point to 85.5% year-over-year revenue growth, expanding margins, and a fortress free cash flow profile; bears flag the trailing valuation, customer concentration risk, and the stock's persistent underperformance versus the S&P 500 over the past year.…
AVGO
Broadcom
$345.22
Related headlines
Investment Opinion: Should I buy AVGO Today?
Rating: Buy (accumulate in stages). The core thesis is that Broadcom's reported fundamentals — 85.5% YoY revenue growth to $29.591B in Q3 2026, a 54.3% operating margin, $39.4B TTM free cash flow, and a forward PE of just 17.06x on consensus FY EPS of $64.01 — are far stronger than the price action implies, and the Street's 49 Buy / 2 Hold / 0 Sell consensus with a $533.42 average target (+60.7% upside) frames the -29% drawdown from record highs as an overreaction rather than a fundamental break.
Supporting evidence is unusually concrete for a stock trading at a discount to its own consensus: revenue compounded sequentially from $18.0B to $19.3B to $22.2B to $29.6B over four quarters with no deceleration, gross margin held in a 67-69% band across eight quarters while operating margin expanded from 44.9% (Q1 2026) to 54.3% (Q3 2026), and net margin nearly doubled from 25.9% to 44.2% year over year. Free cash flow of $13.665B in the quarter on $14.197B of operating cash flow (96.3% conversion) against $23.975B of cash and debt-to-equity of 0.80 means the AI capex build is self-funded, and the PEG of 0.258 versus a trailing PE of 73.8x shows how much of the valuation depends on the forward earnings step-up rather than current cash generation.
The thesis would be invalidated by three developments: a hyperscaler capex pause or deferral of a major custom-ASIC program (semis are ~70% of revenue at $20.839B of $29.591B, concentrated in Anthropic and Google), a break below the $289.77 52-week low that confirms the de-rating is structural, or evidence that consensus FY EPS of $64.01 is unattainable (the low estimate is $40.15). This Buy would upgrade to a high-conviction add on a reclaim of the $375-390 resistance band or a Q4 print showing AI semiconductor growth holding near triple digits, and would downgrade to Hold if revenue growth decelerates below 40% YoY or if the stock closes decisively under $290. On balance the stock is undervalued relative to forward earnings and analyst fair value, but expensive relative to its own trailing history — a classic mispricing that only resolves if the AI order book holds.
Sign up to view all
AVGO 12-Month Price Forecast
The forward-looking case is that Broadcom is a high-quality AI infrastructure compounder trading at a forward earnings discount because the market is discounting the durability of its custom-ASIC order book. Reported evidence supports the bulls — 85.5% revenue growth, 54.3% operating margins, $39.4B FCF, and a PEG of 0.258 — while the bear case rests on what could go wrong (customer concentration in Anthropic and Google, hyperscaler capex sustainability, a 26.74x PS multiple) rather than what has gone wrong. The 25/50/25 bull/base/bear weighting reflects that the base case of a grind back toward the $400-533 range is most probable, with the wide $400-660 analyst target spread signaling genuine uncertainty about AI demand durability. I would upgrade to high confidence on a reclaim of $375-390 or a Q4 print showing AI semiconductor growth above 150%, and downgrade to neutral on a close below $290 or revenue growth decelerating below 40% YoY.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Broadcom's 12-month outlook, with a consensus price target around $533.42 and implied upside of +54.5% versus the current price.
Average Target
$533.42
51 analysts
Implied Upside
+54.5%
vs. current price
Analyst Count
51
covering this stock
Price Range
$400 - $660
Analyst target range
Coverage is exceptionally deep and overwhelmingly bullish: 47 analysts cover Broadcom with a distribution of 49 Buy ratings, 2 Hold, and 0 Sell, yielding a consensus recommendation of "strong_buy" (mean rating 1.24 on a 1-5 scale). The average target price of $533.42 implies roughly +60.7% upside from the current $331.98, a striking gap that underscores how far the stock has fallen below the Street's fair-value estimates. Consensus FY EPS of $64.01 (range $40.15 to $78.20) and revenue of $552.4 billion (range $394.0B to $646.6B) underpin the targets, and the bullish tilt is reinforced by recent institutional actions — DA Davidson upgraded to Buy from Neutral on October 27, Macquarie moved to Outperform from Neutral on September 3, and Rosenblatt, Citigroup, KeyBanc, Evercore, and Raymond James all maintained Buy/Overweight/Outperform ratings through the September-October period.
The target range of $400 (low) to $660 (high) is wide — a 65% spread around the $533 average — signaling meaningful uncertainty about AI demand durability and customer concentration. The high target of $660 assumes multiple expansion on sustained 200%+ AI semiconductor growth, successful ramp of the Anthropic custom-chip program, and continued margin expansion toward 60%+ operating margins; the low target of $400 (still +20.5% above the current price) prices in margin compression, slower hyperscaler capex, or loss of a major custom-ASIC customer. The fact that even the most bearish analyst target sits 20% above the current price, combined with zero Sell ratings and a 1.24 mean recommendation, indicates the Street views the drawdown as an overreaction — though the wide dispersion and the stock's -17.4% relative underperformance versus SPY over the past year suggest conviction is being tested by price action, and investors should treat the consensus as a directional signal rather than a precise forecast given the binary nature of AI capex outcomes.
Bulls vs Bears: AVGO Investment Factors
The bull case currently rests on harder reported evidence: 85.5% YoY revenue growth, 54.3% operating margins, $39.4B TTM free cash flow, and a forward PE of 17.06x against a $533.42 average analyst target (+60.7%). The bear case is largely about what could go wrong rather than what has gone wrong — customer concentration, a 26.74x PS multiple, and a -24.74% six-month relative underperformance that reflects eroding conviction. On balance the fundamental evidence favors the bulls, but the market's price action and the 4.3x trailing-to-forward PE gap show investors are not yet willing to underwrite the consensus earnings step-up. The single most important tension is whether the forward EPS estimate of $64.01 is achievable: if AI custom-silicon revenue holds its 221% growth trajectory and the Anthropic ramp proceeds, the stock is cheap; if hyperscaler capex slows or a major ASIC customer pulls back, the trailing 73.8x multiple becomes the relevant anchor and further downside is likely.
Bullish
- Hyper-growth revenue with sequential acceleration: Q3 2026 revenue of $29.591B grew 85.5% YoY and 33.4% sequentially from $22.187B in Q2, capping a cadence of $18.0B → $19.3B → $22.2B → $29.6B over four quarters. AI semiconductor revenue reportedly surged 221% to $16.7B, showing the growth is AI-driven rather than cyclical recovery. No deceleration is visible in the reported series.
- Best-in-class, expanding margins: Gross margin held at 69.1% in Q3 2026 within a stable 67-69% band across eight quarters, while operating margin climbed from 44.9% in Q1 2026 to 54.3% in Q3 and net margin jumped from 25.9% (Q3 2025) to 44.2%. That operating leverage on a 69% gross margin base is top-decile for semiconductors and reflects pricing power in custom ASICs plus high-margin VMware software mix.
- Fortress cash flow and deleveraging balance sheet: TTM free cash flow is $39.403B with Q3 FCF of $13.665B on $14.197B operating cash flow (96.3% conversion), against $23.975B cash and debt-to-equity of 0.80, down from 0.97 a year ago. Interest coverage of roughly 20.6x means the AI capex build is self-funded, leaving room to both deleverage and invest.
- Extreme analyst conviction and target gap: 49 Buy ratings versus 2 Hold and 0 Sell yield a 1.24 mean recommendation (strong_buy), with an average target of $533.42 implying +60.7% upside from $331.98. Even the lowest target of $400 sits 20.5% above the current price, suggesting the Street views the drawdown as an overreaction.
Bearish
- Severe customer concentration in AI ASICs: Custom AI accelerators now drive roughly 70% of revenue ($20.839B of $29.591B in semis), and the program is heavily tied to a handful of hyperscalers, notably Anthropic and Google. The new Anthropic financing structure reduces per-dollar risk but leaves Broadcom retaining significant single-customer exposure, making the revenue base binary to a few capex decisions.
- Trailing multiples price in perfection: PS of 26.74x, EV/Sales of 17.51x, EV/EBITDA of 50.62x, and P/B of 21.01x are roughly 2-3x typical semiconductor norms, and P/B sits near the top of its own historical range (vs. 8.5x in Q4 2022). The 4.3x gap between trailing (73.8x) and forward (17.06x) PE means the stock only works if EPS roughly quadruples as consensus expects.
- Persistent relative underperformance and downtrend: The stock is -24.51% over six months and -20.21% over three months, with relative strength versus SPY at -24.74% (6M) and -17.42% (1Y). At $331.98 it sits at just 20.6% of its 52-week range ($289.77-$495.00), a structural de-rating rather than a shallow pullback.
- High beta amplifies drawdowns: Beta of 1.508 means roughly 51% more volatility than the S&P 500, and the max drawdown over the period was -39.46%. In a market pullback, a 10% index decline could translate to a ~15% AVGO drawdown, and the November breach to $291.53 shows how quickly the stock can retest lows.
AVGO Technical Analysis
Broadcom is in a sustained, multi-month downtrend despite a modest 1-year decline of only -7.37%, with the current price of $331.98 sitting at just 20.6% of its 52-week range ($289.77 low to $495.00 high) — a positioning that signals the stock has surrendered nearly all of its prior gains and is testing the lower boundary of its annual range. The 6-month change of -24.51% and 3-month change of -20.21% confirm a persistent series of lower highs and lower lows, with the peak near $481.57 in early June giving way to a steady cascade toward the October low of $321.68 and a November intraday breach to $291.53. This is not a shallow pullback but a structural de-rating, and the proximity to the 52-week low means the stock is in "falling knife" territory where value buyers must weigh mean-reversion potential against the risk of a breakdown to new lows.
Short-term momentum remains negative but is showing tentative stabilization: the 1-month change of -8.18% is a meaningful deceleration from the -20.21% three-month decline, suggesting the pace of selling is moderating rather than accelerating. The most recent session printed a +3.91% gain on elevated volume of 28.2 million shares, and the stock has bounced from the $291.53 low to $331.98 — a ~13.8% rebound off the trough — which could mark the early stages of a base-building attempt. However, relative strength remains deeply negative across every window (-4.50% vs. SPY over 1 month, -17.29% over 3 months, -24.74% over 6 months), meaning the bounce is occurring in absolute terms while the stock continues to lag a market that itself fell -3.68% over the past month; this divergence argues the rally is a relief bounce within a downtrend rather than a confirmed reversal.
Key technical levels are clearly defined: support rests at the $289.77 52-week low, with the November spike low of $291.53 reinforcing a double-bottom zone in the $290-292 area; resistance sits at the $495.00 52-week high, with intermediate overhead near the $375-390 region where the stock repeatedly failed in August and October. A decisive break below $290 would signal a new leg lower and likely trigger momentum-driven selling, while a reclaim of $375+ would be the first evidence of a trend change. With a beta of 1.508, Broadcom is roughly 51% more volatile than the S&P 500, and the -39.46% max drawdown over the period underscores that position sizing must account for amplified moves — a 1.5 beta means a 10% market decline could translate to a ~15% drawdown, making stop discipline and staged entry essential at these depressed levels.
Beta
1.51
1.51x market volatility
Max Drawdown
-39.5%
Largest decline past year
52-Week Range
$290-$495
Price range past year
Annual Return
-1.9%
Cumulative gain past year
| Period | AVGO Return | S&P 500 |
|---|---|---|
| 1m | -2.7% | -2.4% |
| 3m | -17.4% | -2.3% |
| 6m | -18.8% | +2.8% |
| 1y | -1.9% | +11.3% |
| ytd | -0.7% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AVGO Fundamental Analysis
Broadcom's revenue trajectory is exceptional and accelerating: fiscal Q3 2026 (quarter ended August 2, 2026) revenue reached $29.591 billion, up 85.5% year over year from $15.952 billion in the year-ago quarter, capping a remarkable run from $19.311 billion in Q1 2026 and $22.187 billion in Q2 2026 — sequential growth of 33.4% in a single quarter. The segment mix shows Semiconductor Solutions at $20.839 billion and Infrastructure Software at $8.752 billion, meaning semis (dominated by custom AI accelerators) now represent roughly 70% of revenue and are the clear growth engine, consistent with reports of AI semiconductor revenue surging 221% to $16.7 billion. This is not merely growth but a step-function re-rating of the business model toward AI infrastructure, and the multi-quarter cadence ($18.0B → $19.3B → $22.2B → $29.6B) shows no sign of deceleration, which underpins the bull case even as the stock de-rates.
Profitability is elite and expanding: Q3 2026 net income hit $13.088 billion (a 44.2% net margin) on gross profit of $20.456 billion (69.1% gross margin), with operating income of $16.058 billion representing a 54.3% operating margin — up sharply from 44.9% in Q1 2026 and 48.9% in Q2 2026. Gross margin has been remarkably stable in the 67-69% band across the last eight quarters (67.1% in Q3 2025, 68.0% in Q4 2025, 68.1% in Q1 2026, 69.5% in Q2 2026, 69.1% in Q3 2026), while operating leverage is driving net margin from 25.9% in Q3 2025 to 44.2% today. For a semiconductor company, a 69% gross margin and 54% operating margin are best-in-class — comparable to or above Nvidia's software-inflected profile — reflecting pricing power in custom ASICs and the high-margin VMware software mix.
Balance sheet and cash generation are strong but carry acquisition-related leverage: trailing free cash flow is $39.403 billion, with Q3 2026 FCF of $13.665 billion on operating cash flow of $14.197 billion (a 96.3% FCF conversion rate), and cash stood at $23.975 billion at quarter-end. Debt-to-equity is 0.80 (down from 0.97 a year ago as the company deleverages), the current ratio is 1.71, and ROE is 28.4% with ROA of 15.4% — robust returns that confirm the business funds growth internally while returning capital ($3.103 billion in dividends paid in Q3, payout ratio 48.2%, dividend yield 0.65%). Interest coverage of ~20.6x and a $39.4 billion FCF run-rate against modest net debt mean financial risk is low; the company is self-funding and has ample capacity to both deleverage and invest in AI capacity.
Quarterly Revenue
$29.6B
2026-08
Revenue YoY Growth
+85.5%
YoY Comparison
Gross Margin
69.1%
Latest Quarter
Free Cash Flow
$39.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AVGO Overvalued?
Because Broadcom is solidly profitable (Q3 2026 net income of $13.088 billion), the PE ratio is the appropriate primary metric. The trailing PE of 73.8x looks extreme, but the forward PE of 17.06x — based on consensus FY EPS estimates averaging $64.01 — reveals the crux of the valuation debate: the market is pricing a massive forward earnings step-up, and the 4.3x gap between trailing and forward multiples implies investors expect EPS to roughly quadruple. This gap is the single most important number in the analysis — if the forward estimate is achieved, the stock is cheap; if AI capex slows and estimates are cut, the trailing multiple is a warning sign. The PEG ratio of 0.258 (well below 1.0) and PS ratio of 26.74 further frame a stock priced for hyper-growth.
Against semiconductor industry averages, Broadcom trades at a substantial premium on most metrics: PS of 26.74x, EV/Sales of 17.51x, EV/EBITDA of 50.62x, and P/B of 21.01x are all well above typical semi-sector norms (the industry's median PS is generally in the high single digits and EV/EBITDA in the high teens to low 20s), representing premiums of roughly 2-3x on sales-based measures. However, the premium is partially justified by superior fundamentals — a 36.2% net margin, 67.8% gross margin, 39.9% operating margin, and 28.4% ROE are top-decile for the sector — and by the 85.5% revenue growth rate that few peers can match. The forward PE of 17.06x is actually a discount to the market and to many AI peers, suggesting the premium is concentrated in trailing metrics that will compress rapidly if earnings materialize.
Historically, Broadcom's valuation sits near the upper end of its own multi-year band on sales-based measures but has compressed sharply on earnings-based ones: the PS ratio has ranged from ~21.6x (Q4 2022) to ~95.2x (Q4 2025) and now sits at 26.74x, while the PE ratio has fallen from 84.6x (Q3 2025) to 73.8x trailing but collapsed to 17.06x forward. The P/B of 21.01x is near the top of its historical range (vs. 8.5x in Q4 2022 and 11.7x in Q4 2024), reflecting both accumulated goodwill from VMware and the market's willingness to pay up for AI exposure. The interpretation is nuanced: on trailing cash-flow and book metrics the stock is expensive relative to its own history, but on forward earnings it is at the cheap end of its range — a classic setup where the market is either dramatically undervaluing future earnings or the consensus estimates are too optimistic.
PE
73.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 15x~85x
vs. Industry Avg
54.4x
Industry PE ~54.4x*
EV/EBITDA
50.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on concentration and the dependence on continued hyper-growth to justify valuation. Semiconductors are roughly 70% of revenue ($20.839B of $29.591B) and are dominated by custom AI accelerators tied to a small set of hyperscalers, so the loss or delay of a single program such as Anthropic or Google would materially dent the fastest-growing segment. The trailing PE of 73.8x versus forward 17.06x requires EPS to roughly quadruple to $64.01; any estimate cut would compress the multiple violently. Leverage is manageable but non-trivial at debt-to-equity of 0.80 with $778M quarterly interest expense, and the 48.2% dividend payout ratio plus VMware integration costs limit flexibility if AI orders slow.
Market and competitive risks are dominated by valuation compression and sector rotation. At PS of 26.74x, EV/EBITDA of 50.62x, and P/B of 21.01x, Broadcom trades at roughly 2-3x semiconductor norms, leaving little room for disappointment; a rotation out of richly valued AI semis has already driven a -24.51% six-month decline and -24.74% relative underperformance versus SPY. Beta of 1.508 means macro shocks hit roughly 1.5x the market, and recent news that Alphabet's free cash flow yield has collapsed to 0.6% and its cloud is cash-flow negative raises the question of how long hyperscaler capex can sustain current order rates. Competitive pressure from merchant GPU alternatives and in-house silicon at other hyperscalers could also erode Broadcom's ASIC share over time.
The worst-case scenario is a hyperscaler capex pause combined with the loss or deferral of a major custom-ASIC program, which would force consensus FY EPS of $64.01 down toward the low estimate of $40.15 and trigger multiple compression toward the trailing range. In that chain, the stock would retest and likely break the $289.77 52-week low, with the November intraday spike to $291.53 confirming that zone as fragile support; a move to the $250-290 area would represent roughly -13% to -25% from the current $331.98. Even the analyst low target of $400 is above the current price, so the realistic downside is technical rather than fundamental — but with a max drawdown of -39.46% already recorded and beta of 1.508, a -30% to -40% adverse move from here is plausible if AI sentiment deteriorates further.
FAQ
The most severe risk is customer concentration: semiconductors are about 70% of revenue ($20.839B of $29.591B) and dominated by custom AI accelerators tied to Anthropic and Google, so a single program deferral would hit the fastest-growing segment directly. Second is valuation compression — PS of 26.74x and EV/EBITDA of 50.62x leave little room for disappointment, and the stock has already fallen -24.51% over six months with -24.74% relative underperformance versus SPY. Third is macro and market sensitivity: beta of 1.508 means a 10% index decline could translate to roughly a 15% drawdown, and the -39.46% max drawdown shows how violent the downside can be. Fourth is the AI capex cycle itself — Alphabet's free cash flow yield has collapsed to 0.6% and its cloud is cash-flow negative, raising questions about how long hyperscalers can sustain the spending that funds Broadcom's ASIC orders.
The scenario framework assigns 50% to a base case of $400-533, 25% to a bull case of $533-660, and 25% to a bear case of $250-400. The base case assumes revenue growth decelerates from 85.5% toward 40-60% as the AI ASIC base grows, margins hold in the high-50s to low-60s, free cash flow stays above $35B, and the forward PE of 17.06x proves too cheap — a grind back toward the $400 low target and the $533.42 average. The bull case requires AI custom-silicon revenue to sustain its 221% trajectory, the Anthropic program to ramp on schedule, and operating margins to push toward 60%, driving a re-rating toward the $660 high target. The bear case is a hyperscaler capex pause combined with a major ASIC deferral, pushing consensus EPS toward $40.15 and the stock below the $289.77 low into the $250-290 zone.
The answer depends entirely on which multiple you anchor to, and that gap is the heart of the debate. On trailing metrics AVGO is expensive: trailing PE of 73.8x, PS of 26.74x, EV/EBITDA of 50.62x, and P/B of 21.01x are roughly 2-3x typical semiconductor norms, and P/B is near the top of its own historical range versus 8.5x in Q4 2022. On forward earnings it is cheap: the forward PE of 17.06x on consensus FY EPS of $64.01 is a discount to the broader market, and the PEG of 0.258 is far below 1.0. The 4.3x gap between trailing and forward PE means the market is pricing an EPS step-up of roughly 4x — if that materializes the stock is undervalued, and if hyperscaler capex slows and estimates fall toward the $40.15 low, the trailing multiple becomes the relevant anchor and the stock is expensive.
From a risk/reward standpoint the setup is asymmetric in the bulls' favor: at $331.98 the stock trades 60.7% below the $533.42 average analyst target, and even the lowest of the 51 analyst targets ($400) sits 20.5% above the current price with zero Sell ratings among 49 Buys and 2 Holds. The fundamental case is supported by 85.5% YoY revenue growth, a 54.3% operating margin, $39.4B TTM free cash flow at 96.3% conversion, and a forward PE of 17.06x on consensus FY EPS of $64.01. The main downside risk is customer concentration — custom AI ASICs are roughly 70% of revenue and tied to a handful of hyperscalers including Anthropic and Google — and a break below the $289.77 52-week low would imply roughly -13% further downside. This makes AVGO a reasonable staged-accumulation candidate for growth investors with a multi-year horizon and tolerance for 1.508 beta volatility, but not a low-risk entry for capital that may be needed within 12 months.
AVGO is structurally a long-term holding, not a trading vehicle. The thesis depends on a multi-year AI infrastructure buildout and on consensus FY EPS of $64.01 materializing — a step-up that cannot be validated in a single quarter — and the 49 Buy / 2 Hold / 0 Sell consensus with a $533.42 average target is a 12-month-plus view. The stock's volatility profile argues against short-term positioning: beta of 1.508, a -39.46% max drawdown, and a -24.51% six-month decline mean momentum traders face whipsaw risk, as shown by the swing from $481.57 in June to $291.53 in November. With a dividend yield of only 0.65% and a 48.2% payout ratio, there is no income cushion to support a short horizon. A minimum holding period of 2-3 years is appropriate, ideally built through staged entries near the $290-330 support zone rather than a single purchase.